TransThera Sciences (Nanjing), Inc. (HKG:2617)
192.00
-2.20 (-1.13%)
At close: Dec 5, 2025
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 76.20 billion as of December 5, 2025.
Market Cap
76.20B
Enterprise Value
75.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
192.00
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 76.20B, an increase of 717.02%. That is a compound annual growth rate of 10,322.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 76.20B | 717.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 277.93B |
| Hansoh Pharmaceutical Group Company | 253.90B |
| JD Health International | 192.73B |
| Innovent Biologics | 157.67B |
| WuXi Biologics | 134.32B |
| Sino Biopharmaceutical | 122.28B |
| Akeso | 114.31B |
| Sichuan Kelun-Biotech Biopharmaceutical | 107.27B |